ACTA1 and fibrodysplasia ossificans progressiva: A member of the TGFβ superfamily, ActA is the requisite ligand for EHO formation in FOP mice [10,21,22,23], and an anti-activin A antibody, garetosumab, is currently in clinical trials for the treatment of FOP.